[1]
Suave, Singla, M., Gupta, S. and Singh, H. 2025. Protocol for a randomized controlled study comparing the efficacy and safety of daily versus alternate day teneligliptin 20 mg in type 2 diabetes mellitus patients. International Journal of Clinical Trials. 12, 2 (Apr. 2025), 153–162. DOI:https://doi.org/10.18203/2349-3259.ijct20251211.